Gaudium IVF’s Bold Expansion: 19 New Centres Planned as Revenue Surges to ₹104 Crore

Gaudium IVF isn’t just scaling — it’s helping rewrite the rules of accessible, tech-driven fertility care in India.

The company’s FY26 results (₹104.35 crore revenue, up 47.6%) and plans to open 19 new centres using IPO proceeds reveal more than corporate ambition. They highlight how a single player is turning a fragmented, under-served market into a structured, high-growth ecosystem.

Why This Expansion Matters Beyond Numbers
India’s fertility sector remains massively untapped — only 2% of infertile couples seek treatment. Gaudium’s hub-and-spoke model, combined with AI tools (Seed & Erica) that lift first-attempt success rates by ~8%, could dramatically close that gap.

By targeting Tier-2 and Tier-3 cities alongside metros, and planning international spokes in places like Nigeria and Paris, the company is positioning itself as both a domestic consolidator and a medical-tourism bridge.

Key Transformative Angles
Democratisation of IVF: Moving from metro-centric, high-cost care to an asset-light network makes treatment more affordable and geographically accessible.
AI as a Game-Changer: The 58% first-attempt clinical pregnancy rate, boosted by technology, points to a future where success rates rise while emotional and financial costs fall.
Regulatory & Ethical Leadership: Full compliance with the 2022 ART law sets a benchmark others may follow as the sector matures.
Economic Ripple Effects: Strong profitability (PAT ₹24.48 crore) and medical-tourism inflows from 30+ countries signal job creation, infrastructure growth, and foreign exchange earnings.
This isn’t just one company’s growth story — it’s an early indicator of how technology, policy support, and private capital could transform infertility from a silent struggle into a manageable, mainstream healthcare priority.

Watch the original interview for deeper context:

Gaudium’s roadmap suggests the next 2–3 years will be pivotal — not only for the company, but for how millions of Indians experience family-building.

Court Permits 51-Year-Old Woman to Undergo IVF Despite Legal Age Restriction

In a notable legal development, the Punjab and Haryana High Court has granted permission to a 51-year-old woman to undergo IVF treatment, even though the Assisted Reproductive Technology (ART) Act sets the age limit for women seeking IVF between 21 and 50 years.

The couple approached the court after a fertility clinic declined treatment on the grounds that the woman had crossed the permissible age. According to court records, the woman had previously undergone IVF in 2023 and successfully delivered a healthy baby girl. Hoping to expand their family further, the couple sought another round of treatment.

During the hearing, the petitioners argued that the woman was medically fit and had no serious health complications that would prevent her from safely carrying a pregnancy. Their counsel also referred to earlier court rulings where exceptions had been made in similar circumstances.

The Union government’s counsel did not oppose the legal precedent but suggested that the couple should submit an undertaking accepting responsibility for any potential risks associated with the treatment.

Justice Jagmohan Bansal accepted this condition and directed the couple to furnish the required undertaking before the fertility centre proceeds with the IVF process.

The judgment has sparked discussion around reproductive rights, medical eligibility, and whether rigid age limits should allow room for exceptional cases. Supporters believe such decisions recognize individual medical conditions and personal circumstances rather than relying solely on numerical age restrictions.

The matter also highlights how courts are increasingly interpreting reproductive laws in a more compassionate and flexible manner, especially when couples demonstrate medical fitness and genuine intent to pursue parenthood.

A similar case was recently seen in the Chhattisgarh High Court, where another couple received permission for IVF treatment under exceptional circumstances after losing their only child. The court observed that reproductive laws should facilitate ethical access to fertility treatment instead of creating unreasonable barriers.

These rulings may influence future legal discussions regarding age-based restrictions in assisted reproductive treatments across India.

GEM Hospital Launches Advanced IVF Centre and Onco-Fertility Programme in Coimbatore

Coimbatore, India – GEM Hospital has announced the launch of its advanced IVF Centre and comprehensive Onco-Fertility Programme in Coimbatore, strengthening access to integrated fertility care and reproductive preservation services for patients across Tamil Nadu and South India.

The newly launched GEM IVF Centre, operating under the hospital’s Endogynaecology Department, is designed to provide personalised fertility treatments supported by advanced reproductive technologies, embryo selection techniques, and specialised care for complex infertility conditions and failed IVF cases.

The department is led by Dr. Sai Darshini and Dr. Saadhvi Balaji under the guidance of Dr. Kavita Yogini, offering patient-centric fertility solutions tailored to individual medical needs.

As part of the expansion, the hospital has also introduced a dedicated fertility preservation programme for women undergoing cancer treatment. The programme enables patients to preserve their fertility through oocyte (egg) freezing prior to chemotherapy or radiotherapy, helping safeguard future reproductive opportunities.

Hospital authorities stated that the integrated facility brings together cancer treatment, fertility preservation, and IVF services under one roof, ensuring seamless multidisciplinary care for patients requiring both oncology and reproductive support.

The launch of the Onco-Fertility Programme highlights the growing importance of fertility preservation in cancer care, especially among young women diagnosed with cancer during their reproductive years.

With the introduction of these specialised services, GEM Hospital aims to strengthen its position as a leading centre for advanced fertility treatment, IVF services, and women’s reproductive healthcare in Coimbatore.

India’s AI Baby Breakthrough – How AI is Transforming IVF in India

India’s AI Baby Breakthrough – How AI is Transforming IVF in India

The journey to parenthood can be one of the most rewarding yet challenging experiences for many families. However, a groundbreaking shift is occurring in reproductive medicine. Gaudium IVF, a leader in India’s fertility sector and the country’s first publicly listed IVF chain, has officially introduced AI-led infertility treatments—marking a significant industry first in India.

This innovation, inaugurated by Hon’ble Union Minister Nitin Jairam Gadkari, represents a move toward a “new era” where precision and intelligence define patient outcomes.

The Technology Behind the Breakthrough

At the heart of this advancement is a partnership with IVF 2.0, a UK-headquartered innovation organization. Together, they have integrated two sophisticated, non-invasive AI systems into routine clinical practice:

     

      • SiD (Sperm Identification Device): This advanced system optimizes the fertilization process by analyzing various sperm movement parameters. By identifying the most viable sperm, SiD helps clinicians create better-quality blastocysts.

      • ERICA (Embryo Ranking Intelligent Classification Assistant): Selecting the right embryo is a critical decision for embryologists. ERICA provides an objective, data-driven ranking by analyzing static images of blastocysts based on their morphological and developmental characteristics.

    By using these “embryology intelligence” systems, clinics can significantly reduce human variability and improve decision-making during the IVF process.

    Why This Matters for Patients

    For many patients, the most significant benefit of AI integration is the potential for improved clinical outcomes. Early observations suggest that these tools can significantly boost fertilization and blastocyst development rates.

    Beyond the lab results, this technology addresses the deep human impact of fertility struggles:

       

        1. Reduced Financial and Physical Burden: Higher success rates mean a reduced need for repeat IVF cycles, which directly lowers the financial and physical toll on patients.

        1. Emotional Relief: Infertility treatments can be emotionally exhausting. Increased predictability and a higher chance of success per cycle help alleviate the stress of the journey.

        1. Transparency and Trust: Dr. Manika Khanna, Chairperson and Managing Director of Gaudium IVF, emphasizes that AI brings greater transparency and trust to the patient journey, allowing for more informed and confident decisions.

      ——————————————————————————–

      A Global Partnership for Local Care

      This milestone was made possible through the collaboration with IVF 2.0, founded by world-renowned embryologists Dr. Jacques Cohen and Dr. Alejandro Chave. This partnership ensures that globally advanced technology is now accessible to patients within the Indian clinical ecosystem.

      As Union Minister Nitin Gadkari remarked during the inauguration, the adoption of such advanced technologies reflects India’s growing strength in innovation and will play a vital role in shaping the future of technology-led healthcare solutions.

      Conclusion

      The integration of AI into fertility care is more than just a technological upgrade; it is a promise of greater precision, consistency, and hope for families across India. By reducing the hurdles of cost and emotional strain, Gaudium IVF and IVF 2.0 are setting new benchmarks for the future of reproductive medicine

      Your daily source for IVF and fertility news across India

      Indian IVF News was built for everyone touched by fertility care in India — the doctors pioneering new treatments, the clinics expanding access across cities and towns, and the patients navigating one of life’s most personal journeys. We bring together the latest research, policy news, clinic updates, and success stories in one trusted place.